13 results
8-K
EX-10.1
QLGN
Qualigen Therapeutics Inc
27 Feb 24
Entry into a Material Definitive Agreement
7:00am
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(oo) Cybersecurity. (i)(x
8-K
EX-10.1
QLGN
Qualigen Therapeutics Inc
22 Dec 22
Entry into a Material Definitive Agreement
4:15pm
of material information regarding the Company or its Subsidiaries or their financial results or prospects.
(oo) Cybersecurity. (i)(x) There has been
424B5
QLGN
Qualigen Therapeutics Inc
1 Dec 21
Prospectus supplement for primary offering
2:28pm
of the cybersecurity insurance Qualigen maintains against such risks. If the information technology systems of its third-party CROs, vendors and other
424B5
QLGN
Qualigen Therapeutics Inc
18 Dec 20
Prospectus supplement for primary offering
1:26pm
be delayed. The costs related to significant security breaches or disruptions could be material and exceed the limits of the cybersecurity insurance Qualigen
424B5
t0kj pdrp
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
wul5zkbcrsho0at
4 Aug 20
Prospectus supplement for primary offering
6:16am
424B5
k3hxfr25
10 Jul 20
Prospectus supplement for primary offering
2:35pm
424B3
lru0c nuo
9 Apr 20
Prospectus supplement
9:30am
S-4/A
ww79fkoh7sqw8v39r eb
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
65jz7vjmp0ms 59h
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
- Prev
- 1
- Next